News Victory for Puma as FDA approves breast cancer drug Neratinib can be used to reduce risk of disease returning.
Views & Analysis What HCPs say about Roche's breast cancer drug The online conversations about breast cancer drug Kadcyla before it was approved by NICE.
News Biosimilars manufacturers close in on Roche cancer blockbust... FDA panel backs Herceptin and Avastin biosimilars.
News Angle poised to take on US cancer diagnostics market Circulating tumour cell test could help select drug therapy.
News Kisqali set for approval - but likely to hit same NICE obsta... Concerns that NICE will reject Kisqali like it did Ibrance.
News Kadcyla finally gets OK after price cut and NICE concessions Roche’s breast cancer drug Kadcyla is set for regular NHS funding in England after the company finally agreed a deal with NICE.
News Grail cancer test gets lukewarm backing from FDA adcomm FDA expert advisors voted in favour of Grail's Galleri blood test for detecting multiple cancers, but some expressed misgivings about its efficacy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
